Using a catheter to improve tricuspid valve treatment planning
Part of Heart & circulation clinical trials.
This trial uses a special catheter to measure blood flow in patients with severe tricuspid regurgitation who are already scheduled for a valve repair or replacement. The goal is to see if this measurement helps doctors better predict who will benefit from the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe or torrential tricuspid regurgitation (a leaky heart valve)
- You are already scheduled to have a procedure to fix or replace your tricuspid valve
- You must be 18 years or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study tests a new catheter-based device (inserted through a vein, not open surgery) to repair a leaky tricuspid heart valve in patients who remain symptomatic despite taking medications. The goal is to improve heart function and quality of life.
This trial tests a new robotic catheter procedure to repair a leaky tricuspid valve (the valve on the right side of your heart). Instead of open-heart surgery, doctors thread a tiny device through a vein in your neck to fix the valve. It may be an option if you have severe leaking and your heart team thinks surgery is too risky for you.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial tests whether a new minimally invasive valve replacement device (put through a catheter) can improve health in people with severe right-sided tricuspid valve leaking. It’s for patients who are considered too high-risk for standard open-heart tricuspid surgery.
Hear when a new Tricuspid Regurgitation (TR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.